Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CymaBay Therapeutics (CBAY)
NASDAQ:CBAY
RESEARCH TOOLSreports
CymaBay Therapeutics (CBAY) Ownership - Who Owns CymaBay Therapeutics?
1,568 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 15, 2024 | Bought | $329991 | |
| Mar 15, 2024 | Sujal Shah Ceo,director | Bought | $655959 |
| Nov 17, 2023 | Daniel Menold Vp Finance | Bought | $60375 |
| Oct 18, 2023 | Daniel Menold Vp Finance | Bought | $60375 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Sold | $450693 | |
| Dec 31, 2023 | Bought | $12565887 | |
| Dec 31, 2023 | Bought | $19880410 | |
| Dec 31, 2023 | Sold | $95056328 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,940,000 | Institution | 10.10% | 225,411,200 | |
| 5,932,903 | Institution | 8.64% | 192,700,689 | |
| 5,104,805 | Institution | 7.43% | 165,804,066 | |
| 4,024,400 | Institution | 5.86% | 130,712,512 | |
| 2,584,216 | Institution | 3.76% | 83,935,336 | |
| 2,015,114 | Institution | 2.93% | 65,450,903 | |
| 1,773,227 | Institution | 2.58% | 57,594,413 | |
| 1,707,326 | Insider | 2.49% | 55,453,948 | |
| 1,647,497 | Institution | 2.40% | 53,510,703 | |
| 1,492,200 | Institution | 2.17% | 48,466,656 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,104,805 | Institution | 7.43% | 165,804,066 | |
| 2,584,216 | Institution | 3.76% | 83,935,336 | |
| 2,015,114 | Institution | 2.93% | 65,450,903 | |
| 1,773,227 | Institution | 2.58% | 57,594,413 | |
| 1,647,497 | Institution | 2.40% | 53,510,703 | |
| 1,492,200 | Institution | 2.17% | 48,466,656 | |
| 1,438,253 | Institution | 2.09% | 46,714,457 | |
| 1,028,353 | Institution | 1.50% | 33,400,905 | |
| 1,007,875 | Institution | 1.47% | 32,735,780 | |
| 759,681 | Institution | 1.11% | 24,674,439 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,523,557 | Institution | 5.13% | 113,423,300 | |
| 1,594,737 | Institution | 2.32% | 51,334,584 | |
| 411,355 | Institution | 0.60% | 13,241,517 | |
| 290,065 | Institution | 0.42% | 9,337,192 | |
| 101,086 | Institution | 0.15% | 3,253,958 | |
| 80,570 | Institution | 0.12% | 2,618,525 | |
| 22,560 | Institution | 0.03% | 732,749 | |
| 8,060 | Institution | 0.01% | 259,451 | |
| 4,043 | Institution | <0.01% | 125,921 | |
| 3,803 | Institution | <0.01% | 89,409 |
FAQ
Who Owns CymaBay Therapeutics (CBAY)?
Currently, no data Available
What percentage of CymaBay Therapeutics (CBAY) stock is held by institutional investors?
Currently, no data Available
What percentage of CymaBay Therapeutics (CBAY) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of CymaBay Therapeutics (CBAY)?
Peter Kolchinsky owns the most shares of CymaBay Therapeutics (CBAY).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.